RET Rearrangements in Lung Adenocarcinoma and Radiation
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 9 (1) , 118-120
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase FusionsClinical Cancer Research, 2012
- RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2012
- Identification of CCDC6-RET Fusion in the Human Lung Adenocarcinoma Cell Line, LC-2/adJournal of Thoracic Oncology, 2012
- RET, ROS1 and ALK fusions in lung cancerNature Medicine, 2012
- KIF5B-RET fusions in lung adenocarcinomaNature Medicine, 2012
- A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencingGenome Research, 2011
- Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomasLaboratory Investigation, 2010
- RET/PTC Rearrangements Preferentially Occurred in Papillary Thyroid Cancer among Atomic Bomb Survivors Exposed to High Radiation DoseCancer Research, 2008
- Dose-Dependent Generation of RET/PTC in Human Thyroid Cells after in Vitro Exposure to γ-Radiation: A Model of Carcinogenic Chromosomal Rearrangement Induced by Ionizing RadiationThe Journal of Clinical Endocrinology & Metabolism, 2005
- High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiationOncogene, 1997